MERKEL, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.800
AS - Asia 4.039
EU - Europa 3.105
SA - Sud America 693
AF - Africa 95
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 6
Totale 26.751
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.732
SG - Singapore 1.794
CN - Cina 1.032
HK - Hong Kong 774
BR - Brasile 648
FI - Finlandia 566
IT - Italia 432
DE - Germania 423
PL - Polonia 359
SE - Svezia 311
FR - Francia 266
UA - Ucraina 242
VN - Vietnam 192
RU - Federazione Russa 168
GB - Regno Unito 165
TR - Turchia 53
IN - India 51
NL - Olanda 44
IE - Irlanda 42
CA - Canada 35
IQ - Iraq 20
ZA - Sudafrica 20
GR - Grecia 19
BD - Bangladesh 18
MX - Messico 13
AR - Argentina 12
AT - Austria 11
PK - Pakistan 11
VE - Venezuela 10
JP - Giappone 9
EC - Ecuador 8
JO - Giordania 8
KE - Kenya 8
MA - Marocco 8
RO - Romania 8
TH - Thailandia 8
CI - Costa d'Avorio 7
EG - Egitto 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
BG - Bulgaria 6
EU - Europa 6
LB - Libano 6
CO - Colombia 5
CZ - Repubblica Ceca 5
ES - Italia 5
ET - Etiopia 5
IL - Israele 5
NP - Nepal 5
PT - Portogallo 5
SA - Arabia Saudita 5
TT - Trinidad e Tobago 5
AL - Albania 4
DK - Danimarca 4
GA - Gabon 4
LY - Libia 4
MY - Malesia 4
NZ - Nuova Zelanda 4
SI - Slovenia 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
BY - Bielorussia 3
ID - Indonesia 3
KG - Kirghizistan 3
PE - Perù 3
PG - Papua Nuova Guinea 3
PY - Paraguay 3
SN - Senegal 3
AD - Andorra 2
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
BF - Burkina Faso 2
BN - Brunei Darussalam 2
CG - Congo 2
CH - Svizzera 2
CV - Capo Verde 2
DZ - Algeria 2
GE - Georgia 2
GN - Guinea 2
HT - Haiti 2
JM - Giamaica 2
KR - Corea 2
KY - Cayman, isole 2
KZ - Kazakistan 2
LT - Lituania 2
LV - Lettonia 2
NA - Namibia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
TW - Taiwan 2
ZM - Zambia 2
AF - Afghanistan, Repubblica islamica di 1
BE - Belgio 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
BZ - Belize 1
Totale 26.723
Salva come PNG Salva come JPEG
Città #
Fairfield 2.610
Woodbridge 1.857
Houston 1.644
Ann Arbor 1.410
Chandler 1.343
Jacksonville 1.133
Ashburn 1.102
Wilmington 1.068
Seattle 938
Singapore 895
Cambridge 889
Hong Kong 773
Boardman 537
Princeton 531
Santa Clara 406
Bytom 356
Medford 287
San Diego 260
Nanjing 224
Dong Ket 180
Beijing 177
Helsinki 176
Des Moines 164
Roxbury 148
Guangzhou 90
Norwalk 75
Shenyang 73
Hebei 72
Padova 69
Nanchang 66
Changsha 57
Jiaxing 50
Dublin 41
Munich 40
São Paulo 40
Tianjin 32
Yenibosna 32
London 30
Rome 30
New York 28
Redwood City 27
Kharkiv 25
Falkenstein 19
Belo Horizonte 18
Chicago 18
Jinan 18
Los Angeles 18
Rio de Janeiro 14
Brasília 13
Dearborn 12
Ogden 12
Porto Alegre 12
Sorocaba 11
Ankara 10
Campinas 10
Curitiba 10
Dallas 10
Kunming 10
Ottawa 10
Borås 9
Hounslow 9
Milan 9
Recife 9
Zhengzhou 9
Amman 8
Baghdad 8
Cape Town 8
Falls Church 8
Las Vegas 8
Nairobi 8
Abidjan 7
Amsterdam 7
Atlanta 7
Genoa 7
Ho Chi Minh City 7
Nuremberg 7
San Francisco 7
Tashkent 7
Venice 7
Vienna 7
Washington 7
Baku 6
Bologna 6
Boston 6
Florence 6
Goiânia 6
Hangzhou 6
Johannesburg 6
Juiz de Fora 6
Kilburn 6
Ningbo 6
Paris 6
Praia Grande 6
Rockville 6
Salvador 6
Taizhou 6
Tokyo 6
Toronto 6
Turku 6
Varese 6
Totale 20.494
Salva come PNG Salva come JPEG
Nome #
The animal naming test: An easy tool for the assessment of hepatic encephalopathy 209
Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats. 161
The self-morningness/eveningness (Self-ME): An extremely concise and totally subjective assessment of diurnal preference 156
A SIMPLIFIED PSYCHOMETRIC EVALUATION FOR THE DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY 152
Acute liver rejection: Accuracy and predictive values of Doppler US measurements - Initial experience 152
Interobserver and inter-equipment variability of echo-Doppler sonographic evaluation of the superior mesenteric artery. 148
Clinical value of asterixis in 374 well-characterised patients with cirrhosis and varying degree of hepatic encephalopathy 142
Training of Italian emergency medicine residents in prehospital emergency medicine:state of the art and perspectives of improvement 139
Ammonia-related changes in cerebral electrogenesis in healthy subjects and patients with cirrhosis. 138
A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis 137
Nutrition and survival in patients with liver cirrhosis 137
Change in portal flow after liver transplantation: effect on hepatic arterial resistance indices and role of spleen size 132
Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as guidance for prophylaxis and treatment of bleeding and re-bleeding? Yes! 129
Effect of somatostatin on liver blood flow and liver metabolic activity in patients with cirrhosis. 129
New abdominal collaterals at ultrasound: A clue of progression of portal hypertension 129
Blood flow of experimental liver metastases in rat as evaluated by the locally injected 133-Xenon washout. 128
Beta-blockers in the prevention of aggravation of esophageal varices in patients with cirrhosis and small varices: a placebo-controlled clinical trial. 128
Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. 127
A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis 127
Haeme oxygenase mediates hyporeactivity to phenylephrine in the mesenteric vessels of cirrhotic rats with ascites 125
Electroencephalography in patients with cirrhosis. 124
Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension 124
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 124
Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria 123
EVALUATION OF SPLANCHNIC ANGIOGRAPHY AS A PROGNOSTIC INDEX OF SURVIVAL IN PATIENTS WITH CIRRHOSIS 122
Incidence and natural history of small esophageal varices in cirrhotic patients 121
Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats 119
Encephalopathy or hepatic encephalopathy? 119
Different hemodynamic patterns of alcoholic and viral endstage cirrhosis: analysis of explanted liver weight, degree of fibrosis and splanchnic Doppler parameters 119
Hepatitis C virus reinfection in liver transplant patients: evaluation of liver damage progression with echo-color doppler. 115
Visual attention in cirrhotic patients: a study on covert visual attention orienting. 114
Theophylline pharmacokinetics and liver function indexes in chronic liver disease. 114
The Influence of Environmental Factors on Sleep Quality in Hospitalized Medical Patients 114
Cost-effectiveness analysis of beta-blockers vs endoscopic surveillance in patients with cirrhosis and small varices 113
Renal water and sodium handling in compensated liver cirrhosis: mechanism of the impaired natriuresis after saline loading. 113
Effects of chronic therapy with nadolol on portal hemodynamics and on splanchnic impedance indices using Doppler sonography: Comparison between acute and chronic effects 111
Renal haemodynamics in essential hypertension assessed by 133-Xenon washout and selective renal angiography 111
Portal hypertension and portal hypertensive gastropathy in patients with liver cirrhosis: a haemodynamic study 111
Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow. 110
Metabolic control of kidney hemodynamics in normal and insulin-dependent diabetic subjects. Effects of acetoacetic, lactic, and acetic acids. 110
Interobserver and inter-equipment variability of echo-Doppler evaluation of the superior mesenteric artery. 109
Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis. 109
Renal effects of nadolol in cirrhosis. 109
Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease 109
Hepatitis C Virus Reinfection in Liver Transplant Patients: Evaluation of Liver Damage Progression with Echo-Color Doppler 109
Simple tools for complex syndromes: A three-level difficulty test for hepatic encephalopathy 109
A short cut to predict the clinical response to beta-blocker therapy in cirrhosis? 108
Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost 107
Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension. 107
Prognostic Benefit of the Addition of a Quantitative Index of Hepatic Encephalopathy to the MELD score: the MELD-EEG 107
Accuracy and predictive value of echo-Doppler measurements in acute liver rejection -- initial experience 106
Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trial. 106
Prognostic benefit of the addition of an electroencephalographic (EEG) index to the MELD score: the MELD-EEG. 106
Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats with ascites 106
HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients 106
Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension 105
Il timing del trapianto di fegato: Child-Pugh o Mayo score? 105
Heme oxygenase regulates the response of intrarenal arteries to alpha-adrenergic stimulation in experimental cirrhosis. 104
Carbon monoxide-mediated activation of a large-conductance calcium-activated potassium channels contrinutes to mesenteric vasodilation in cirrhotic rats. 321 : 187-194. 103
Long-term effects of beta-adrenergic blockade with nadolol on hepatic and renal haemodynamics and function in cirrhotics. 103
Natural History of cirrhotic patients with small esophageal varices: a prospective study 102
Bright times for patients with cirrhosis and delayed sleep habits: a case report of the beneficial effect of light therapy 102
Confounders in the detection of minimal hepatic encephalopathy: a neuropsychological and quantified EEG study. 102
Sleep-wake abnormalities in patients with cirrhosis. 101
A COST-EFFECTIVENESS ANALYSIS OF PROPHYLAXIS OF VARICEAL BLEEDING STARTING FROM SMALL ESOPHAGEAL VARICES COMPARED TO SURVEILLANCE AND TREATMENT STARTING FROM LARGE ONES 100
Hemodynamic and clinical evaluation of nadolol in the treatment of portal hypertension in patients with cirrhosis. 100
Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. 99
Endotoxins and the hepatorenal syndrome. 99
AISF practice guidelines for portal hypertension.Committee for portal hypertension of the Italian Association for the Study of the Liver. 98
Intrarenal blood flow, circulation time, and cortical vascular volume in patients with cirrhosis. 98
PLASMA CARNITINE LEVELS IN LIVER-CIRRHOSIS - RELATIONSHIP WITH NUTRITIONAL-STATUS AND LIVER-DAMAGE 97
Attention: Minimal hepatic encephalopathy and road accidents 97
Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as time-dependent covariates 97
Porcine and human insulin absorption from subcutaneous tissues in normal and insulin dependent diabetic subjects: a deconvolution-based approach 96
Hemodynamic and clinical evaluation of nadolol in the treatment of portal hypertension in patients with cirrhosis. 96
Optimizing the time-frame for the definition of bleeding-related death after acute variceal bleeding in cirrhosis 95
IgM-linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease 95
Validation of a predictive model for chronic renal dysfunction following liver transplantation. 95
Agreement and predictive validity of neurophysiological, psychometric, and psychophysical indices of hepatic encephalopathy. 95
The cirrhotic patient with no varices and with small varices 94
Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis 94
Nutritional and prognostic significance of serum hypothyroxinemia in hospitalized patients with liver cirrhosis 94
Vascularization of experimental liver metastases. 2 - Blood flow. 94
The use of human albumin millimicrospheres tagged with 99mTc in the evaluation of the removal capacity of the reticuloendothelial system. 93
Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis. 93
Prevention of the formation and growth of esophageal varices 93
Covert hepatic encephalopathy: Agreement and predictive validity of different indices 93
Value of prealbumin plasma levels as liver test. 92
Cirrhosis and muscle cramps: evidence of a causal relationship. 92
Malnutrition in alcoholic and virus-related cirrhosis 92
Short-term effects of transcatheter arterial chemoembolisation on metabolic activity of the liver of cirrhotic patients with hepatocellular carcinoma 92
Evaluation of renal tubular damage in liver cirrhosis by urinary enzymes and beta-2-microglobulin excretions. 91
Splenic Doppler impedance indices: influence of different portal hemodynamic conditions. 90
Primary Prophylaxis of Bleeding from Esophageal Varices in Cirrhosis 90
Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients 90
Effect of nadolol on liver haemodynamics and function in patients with cirrhosis. 90
The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis 89
Lowering portal pressure improves outcomes of patients with cirrhosis, with or without ascites: a meta-analysis. 89
Cost-effective analysis of primary prophylaxis of variceal bleeding with beta-blockers vs. endoscopic surveillance in cirrhotic patients with small esophageal varices. 88
Tubular handling of sodium and water in liver cirrhosis 88
Totale 11.074
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.945
article - articoli 74.164
book - libri 866
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.242
Totale 175.217
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020234 0 0 0 0 0 0 0 0 0 0 0 234
2020/20212.593 123 212 60 195 103 255 71 272 394 253 319 336
2021/20223.553 56 577 371 212 188 169 135 354 207 52 346 886
2022/20232.937 699 244 79 281 495 436 3 186 344 18 112 40
2023/20241.093 63 205 102 85 58 58 33 33 45 23 191 197
2024/20256.041 9 481 323 261 1.009 118 245 411 602 239 1.086 1.257
Totale 26.831